LFMD Quote, Financials, Valuation and Earnings

Veradigm, Inc. has a net margin of -5.91% compared to LifeMD, Inc.'s net margin of --. LifeMD, Inc.'s return on equity of -- beat Veradigm, Inc.'s return on equity of --.

LifeMD, Inc. has a consensus price target of $9.25, signalling upside risk potential of 139.64%. On the other hand Veradigm, Inc. has an analysts' consensus of $5.83 which suggests that it could grow by 25.45%. Given that LifeMD, Inc. has higher upside potential than Veradigm, Inc., analysts believe LifeMD, Inc. is more attractive than Veradigm, Inc..

LifeMD, Inc. has a beta of 1.456, which suggesting that the stock is 45.566% more volatile than S&P 500. In comparison Veradigm, Inc. has a beta of 0.510, suggesting its less volatile than the S&P 500 by 49.042%.

LifeMD, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Veradigm, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. LifeMD, Inc. pays 16.59% of its earnings as a dividend. Veradigm, Inc. pays out -- of its earnings as a dividend. LifeMD, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

LifeMD, Inc. quarterly revenues are $60.2M, which are larger than Veradigm, Inc. quarterly revenues of --. LifeMD, Inc.'s net income of -$3.6M is higher than Veradigm, Inc.'s net income of --. Notably, LifeMD, Inc.'s price-to-earnings ratio is -- while Veradigm, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for LifeMD, Inc. is 0.68x versus 0.86x for Veradigm, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Semler Scientific, Inc. has a net margin of -5.91% compared to LifeMD, Inc.'s net margin of -732.34%. LifeMD, Inc.'s return on equity of -- beat Semler Scientific, Inc.'s return on equity of 18.3%.

LifeMD, Inc. has a consensus price target of $9.25, signalling upside risk potential of 139.64%. On the other hand Semler Scientific, Inc. has an analysts' consensus of $65.67 which suggests that it could grow by 239.01%. Given that Semler Scientific, Inc. has higher upside potential than LifeMD, Inc., analysts believe Semler Scientific, Inc. is more attractive than LifeMD, Inc..

LifeMD, Inc. has a beta of 1.456, which suggesting that the stock is 45.566% more volatile than S&P 500. In comparison Semler Scientific, Inc. has a beta of 1.316, suggesting its more volatile than the S&P 500 by 31.636%.

LifeMD, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Semler Scientific, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. LifeMD, Inc. pays 16.59% of its earnings as a dividend. Semler Scientific, Inc. pays out -- of its earnings as a dividend. LifeMD, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

LifeMD, Inc. quarterly revenues are $60.2M, which are larger than Semler Scientific, Inc. quarterly revenues of $7.5M. LifeMD, Inc.'s net income of -$3.6M is lower than Semler Scientific, Inc.'s net income of $16.9M. Notably, LifeMD, Inc.'s price-to-earnings ratio is -- while Semler Scientific, Inc.'s PE ratio is 6.97x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for LifeMD, Inc. is 0.68x versus 6.31x for Semler Scientific, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Streamline Health Solutions, has a net margin of -5.91% compared to LifeMD, Inc.'s net margin of -34.2%. LifeMD, Inc.'s return on equity of -- beat Streamline Health Solutions,'s return on equity of -64.34%.

LifeMD, Inc. has a consensus price target of $9.25, signalling upside risk potential of 139.64%. On the other hand Streamline Health Solutions, has an analysts' consensus of $22.50 which suggests that it could fall by -71.91%. Given that LifeMD, Inc. has higher upside potential than Streamline Health Solutions,, analysts believe LifeMD, Inc. is more attractive than Streamline Health Solutions,.

LifeMD, Inc. has a beta of 1.456, which suggesting that the stock is 45.566% more volatile than S&P 500. In comparison Streamline Health Solutions, has a beta of 2.070, suggesting its more volatile than the S&P 500 by 106.993%.

LifeMD, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Streamline Health Solutions, offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. LifeMD, Inc. pays 16.59% of its earnings as a dividend. Streamline Health Solutions, pays out -- of its earnings as a dividend. LifeMD, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

LifeMD, Inc. quarterly revenues are $60.2M, which are larger than Streamline Health Solutions, quarterly revenues of $4.8M. LifeMD, Inc.'s net income of -$3.6M is lower than Streamline Health Solutions,'s net income of -$1.6M. Notably, LifeMD, Inc.'s price-to-earnings ratio is -- while Streamline Health Solutions,'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for LifeMD, Inc. is 0.68x versus 1.18x for Streamline Health Solutions,. Usually stocks with elevated PS ratios are considered overvalued.

TruBridge, Inc. has a net margin of -5.91% compared to LifeMD, Inc.'s net margin of 6.3%. LifeMD, Inc.'s return on equity of -- beat TruBridge, Inc.'s return on equity of 1.61%.

LifeMD, Inc. has a consensus price target of $9.25, signalling upside risk potential of 139.64%. On the other hand TruBridge, Inc. has an analysts' consensus of $22.60 which suggests that it could grow by 5.07%. Given that LifeMD, Inc. has higher upside potential than TruBridge, Inc., analysts believe LifeMD, Inc. is more attractive than TruBridge, Inc..

LifeMD, Inc. has a beta of 1.456, which suggesting that the stock is 45.566% more volatile than S&P 500. In comparison TruBridge, Inc. has a beta of 0.607, suggesting its less volatile than the S&P 500 by 39.29%.

LifeMD, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. TruBridge, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. LifeMD, Inc. pays 16.59% of its earnings as a dividend. TruBridge, Inc. pays out -- of its earnings as a dividend. LifeMD, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

LifeMD, Inc. quarterly revenues are $60.2M, which are smaller than TruBridge, Inc. quarterly revenues of $86.1M. LifeMD, Inc.'s net income of -$3.6M is lower than TruBridge, Inc.'s net income of $5.4M. Notably, LifeMD, Inc.'s price-to-earnings ratio is -- while TruBridge, Inc.'s PE ratio is 115.40x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for LifeMD, Inc. is 0.68x versus 0.90x for TruBridge, Inc.. Usually stocks with elevated PS ratios are considered overvalued.